How does Campral® (acamprosate) work in the maintenance of abstinence from alcohol?
Campral®, which was recently approved by the FDA, is a drug developed in Germany and prescribed extensively throughout Europe for the past several years. It will soon be available to clinicians and patients in the U.S. and will be included in The Freedom From Alcohol® Method treatment. As an alternative or in concert with naltrexone treatment, Campral® will also be offered in conjunction with supportive counseling and coaching, just as with naltrexone. The key difference is that Campral® is taken by patients with alcohol dependence on the days they are abstinent during their treatment, along with coaching to maintain optimal performance. Campral® offers an additional tool to support the control and moderation of alcohol craving. Campral® and naltrexone can be prescribed on differing days as appropriate.
